Key Takeaways
There's no fixed timeline for stopping HRT
Most women stay on hormone therapy for three to five years or longer, and the decision to continue or wean off is personal rather than automatic. Dr. Cat noted that many physicians, herself included, plan to stay on HRT indefinitely because of the ongoing symptom relief and long-term health benefits.
Breast tenderness early on isn't a red flag
Mild breast tenderness in the first weeks of HRT is common and usually resolves as the body adjusts. Dr. Green explained that persistent tenderness can signal a dose needs adjusting, but on its own it isn't a sign of increased breast cancer risk.
"Bioidentical" describes structure, not automatic safety
Bioidentical hormones are chemically identical to what the body produces, which allows for lower effective doses than synthetic versions. Dr. Cat was clear that "bioidentical" is a descriptive term, not a guarantee of zero risk — every hormone, like any medication, carries some level of risk.
Cream vs. patch comes down to lifestyle, not superiority
Both delivery methods work well for most women; the patch offers steady, timed release but costs more, while the cream is compounded in-house and typically less expensive. Dr. Green cautioned against assuming the pricier option is automatically the better one.
Consistency matters more than cycling
Taking a steady daily dose tends to produce more reliable symptom relief than cycling doses through the month. Dr. Green noted that newer research walked back earlier assumptions that cycling progesterone reduced risk, since in practice it mostly added breakthrough bleeding without extra benefit.
